Methylseleninic Acid Sensitizes Ovarian Cancer Cells to T-Cell Mediated Killing by Decreasing PDL1 and VEGF Levels

about

Methylseleninic Acid Sensitizes Ovarian Cancer Cells to T-Cell Mediated Killing by Decreasing PDL1 and VEGF Levels

Item

http://www.wikidata.org/entity/Q57490205

description

wetenschappelijk artikel

@nl

наукова стаття, опублікована у 2018

@uk

name

Methylseleninic Acid Sensitize ...... ecreasing PDL1 and VEGF Levels

@en

Methylseleninic Acid Sensitize ...... ecreasing PDL1 and VEGF Levels

@nl

type

Item

label

Methylseleninic Acid Sensitize ...... ecreasing PDL1 and VEGF Levels

@en

Methylseleninic Acid Sensitize ...... ecreasing PDL1 and VEGF Levels

@nl

prefLabel

Methylseleninic Acid Sensitize ...... ecreasing PDL1 and VEGF Levels

@en

Methylseleninic Acid Sensitize ...... ecreasing PDL1 and VEGF Levels

@nl

P1476

Methylseleninic Acid Sensitize ...... ecreasing PDL1 and VEGF Levels

@en

P2093

Aristi P Fernandes

http://www.w3.org/2001/XMLSchema#string

Axel Schröder

http://www.w3.org/2001/XMLSchema#string

Charlotte Klynning

http://www.w3.org/2001/XMLSchema#string

Deepika Nair

http://www.w3.org/2001/XMLSchema#string

Emelie Rådestad

http://www.w3.org/2001/XMLSchema#string

Johanna Ungerstedt

http://www.w3.org/2001/XMLSchema#string

Michael Uhlin

http://www.w3.org/2001/XMLSchema#string

Nuria Diaz-Argelich

http://www.w3.org/2001/XMLSchema#string

Prajakta Khalkar

http://www.w3.org/2001/XMLSchema#string

P2860

Methylseleninic acid restricts tumor growth in nude mice model of metastatic breast cancer probably via inhibiting angiopoietin-2

Angiogenesis as a therapeutic target

Differential effects of selenium on benign and malignant prostate epithelial cells: stimulation of LNCaP cell growth by noncytotoxic, low selenite concentrations.

Methyl-selenium compounds inhibit prostate carcinogenesis in the transgenic adenocarcinoma of mouse prostate model with survival benefit

The selenium metabolite methylselenol regulates the expression of ligands that trigger immune activation through the lymphocyte receptor NKG2D

Exhaustion of tumor-specific CD8⁺ T cells in metastases from melanoma patients

VEGF-A modulates expression of inhibitory checkpoints on CD8+ T cells in tumors.

Tumor secretion of VEGF induces endothelial cells to suppress T cell functions through the production of PGE2.

VEGF directly suppresses activation of T cells from ascites secondary to ovarian cancer via VEGF receptor type 2

Tumor-induced tolerance and immune suppression by myeloid derived suppressor cells.

P304

407

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3389/FONC.2018.00407

http://www.w3.org/2001/XMLSchema#string

P407

English

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

30324091

http://www.w3.org/2001/XMLSchema#string

P921

ovarian cancer

cancer research

P932

6172341

http://www.w3.org/2001/XMLSchema#string